ArticleInternational journal of molecular sciences2020

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors.

Ana J Rodrigues Moita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.